April 2017 Briefing – Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for April 2017. This roundup includes the latest...
April 2017 Briefing – Infectious Disease
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for April 2017. This roundup includes the...
April 2017 Briefing – HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for April 2017. This roundup includes...
April 2017 Briefing – Gastroenterology
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for April 2017. This roundup includes the latest...
April 2017 Briefing – Family Practice
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for April 2017. This roundup includes the...
April 2017 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for April 2017. This roundup includes...
April 2017 Briefing – Dermatology
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for April 2017. This roundup includes the latest...
April 2017 Briefing – Cardiology
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for April 2017. This roundup includes the latest...
April 2017 Briefing – Allergy
Here are what the editors at HealthDay consider to be the most important developments in Allergy for April 2017. This roundup includes the latest...
FDA Approves Kinase Inhibitor for Treatment of AML
Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults
